SCHEMBL30578960

SCHEMBL30578960

CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C

nearest known ligand 0.45

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 10/20 0.45
▸ NPY4R P50391 8/20 0.45
▸ NPY1R P25929 6/20 0.45
▸ NPY2R P49146 4/20 0.45
▸ NPY5R Q15761 4/20 0.45
▸ CTSD P07339 2/20 0.45
▸ BACE2 Q9Y5Z0 2/20 0.45
▸ VIPR2 P41587 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29911841 0.93 BACE1 (0.45) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL29837349 0.91 TFPI (0.46) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL29837350 0.91 TFPI (0.47) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL30692435 0.91 TFPI (0.47) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL30262050 0.90 TFPI (0.50) BACE1CTSDBACE2
SCHEMBL29524799 0.90 BACE1 (0.42) BACE1NPY4RNPY1RNPY2RNPY5R
SCHEMBL30578958 0.89 BACE1 (0.52) BACE1CTSDBACE2
SCHEMBL31753635 0.89 NPY4R (0.52) NPY4RNPY1RNPY2RNPY5R
SCHEMBL29883992 0.89 NPY4R (0.52) NPY4RNPY1RNPY2RNPY5R
SCHEMBL30544289 0.88 NPY4R (0.52) NPY4RNPY1RNPY2RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12351651-B2 Polypeptide for repairing mucosal damage or skin wound and use thereof SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) 2025-07-08 — — US disclosed
US-20230295233-A1 POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF SICHUAN GOODDOCTOR PANXI PHARMACEUTICAL CO., LTD. (CN) 2023-09-21 — — US disclosed
Send feedback